Article Information
History
- October 12, 2022.
Article Versions
- Version 1 (May 17, 2022 - 20:54).
- Version 2 (July 5, 2022 - 09:30).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
- 2Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts
- 3Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Boston, Massachusetts
- 4Harvard Medical School, Boston, Massachusetts
- ↵*Please address correspondence to: Christopher Cassa cassa{at}alum.mit.edu
Author Contributions: Data curation: V.B.; Formal analysis: V.B.; Software: V.B., I.A.A., J.D.F.; Writing-original draft: V.B., C.A.C.; Writing-review & editing: V.B., C.A.C., M.L., I.A.A., J.D.F.
Posted October 12, 2022.
Informing Variant Assessment using Structured Evidence from Prior Classifications (PS1, PM5, and PVS1 Sequence Variant Interpretation Criteria)
